Inspyr Therapeutics (OTC:NSPX) STOCK VOLATILITY FACTOR :
Average true range percent (ATRP-14) measured at 100%. Volatility or average true range percent (ATRP 14) is the ATR expressed as a percentage of closing price. Average true range percent (ATRP) measures volatility on a relative level. This is opposed to the ATR, which measures volatility on an absolute level. ATRP allows securities to be compared whereas ATR does not. That means lower-priced stocks won’t necessarily have lower ATR values than higher-priced stocks. The Company’s beta coefficient sits at 0.316282. Beta factor measures the amount of market risk associated with market trade. Higher the beta discloses more riskiness and lower the beta lower the risk.
Inspyr Therapeutics (OTC:NSPX) has five years performance of -99.989147% and weekly performance of -58%. The stock has been moved at -94.75% throughout last twelve months. The stock has performed -58% around last thirty days, and changed -58% over the last three months.
Inspyr Therapeutics (OTC:NSPX) stock has performed -2.33% and changed $-0.0001 while share value reached at $0.0042 in last trading session. At present, the stock 52 week high price sited at 0.15 and 52 week low situated at 0. 529468 shares traded on hands while it’s an average volume stands with 286202 shares. The current analyst consensus rating clocked at 2 on company shares. Analysts estimated that stock to reach value at $0.85 price in one-year period.
The company’s net profit margin is 0.00%. It measures how much out of every dollar of sales a company actually keeps in earnings. Operating Margin is seen at 0.00%. Return on Assets (ROA) an indicator of how profitable a company is relative to its total assets is -126.15%.
MARKET CAPITALIZATION AND VALAATION INDICATORS:
Inspyr Therapeutics (OTC:NSPX) is United States based company. Currently it has a market worth of $41189. Using market capitalization to show the size of a company is important because company size is a basic determinant of various characteristics in which investors are interested, including risk. Forward P/E is standing at -0.014828. Forward P/E is a measure of the price-to-earnings ratio using forecasted earnings for the P/E calculation for the next fiscal year.
Now The company has RSI figure of 39.68. The Relative Strength Index (RSI) was developed by J. Welles Wilder, and it reading fluctuates between 0 and 100. The RSI is a momentum oscillator that measures the speed and change of stock price movements. Generally, the when RSI falls below 30 then stock considered to be oversold and overbought when it moves above 70. The normal reading of a stock will fall in the range of 30 to 70. RSI can be used to detect general trends as well as finding divergences and failure swings.
ADX value listed at 53.59. The values of ADX range from 0 to 100 and are also important for distinguishing between trends and non-trends. Many traders will use ADX readings above 25 to suggest that the trend’s strength is strong enough for trend trading strategies. Conversely, when ADX is below 25, many will avoid trend trading strategies.
Category – Market Movers
Hank Winkel has over 10 years of experience as a professional journalist, writer and an editor. He holds a bachelor’s degree in International Business from University of Melbourne. He studied a business degree majoring in finance and security analysis. He has a deep understanding of both technical and fundamental forms of analysis, he deeply believes that it makes a lot more sense for average investors to understand fundamental analysis, which he believes anyone can learn. Hank writes articles about Market Movers, dividend growth investing, options trading, investment decisions, stock selection, portfolio management, and passive income generation. Hank Winkel primarily reports on Market Movers category.
Email Contact: Hank@nysewired.com